InvestorsObserver is giving Spectrum Pharmaceuticals, Inc. (SPPI) an Analyst Rating Rank of 54, meaning SPPI is ranked higher by analysts than 54% of stocks. The average price target for SPPI is $6.75 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating SPPI a Strong Buy today. Find out what this means to you and get the rest of the rankings on SPPI!